menu ☰
menu ˟

Senseonics begins trial of 6-month glucose sensor in US

12 Jan 2019
Senseonics has enrolled its first U.S. patient in a clinical trial for its 180-day extended-wear continuous glucose monitoring sensor as part of a premarket application submission to the FDA, according to a press release from the company.The PROMISE ...

Click here to view the full article which appeared in Endocrinology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.